Get the Stockscreener App
3.26
46.99%
-2.89
After Hours:
3.30
0.04
+1.23%
Endra Life Sciences Inc Stock (NDRA) Forecast
The Endra Life Sciences Inc (NDRA) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $7.6173, representing a +133.66% increase from the current price of $3.26. The highest analyst price target is $7.2226, and the lowest is $8.0119.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month NDRA Price Target
Average 22.91
(+602.91% Upside)
Is Endra Life Sciences Inc (NDRA) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 40.26 | Neutral |
| STOCH(9,6) | 57.35 | Neutral |
| STOCHRSI(14) | 63.15 | Neutral |
| MACD(12,26) | 0.389 | Sell |
| ADX(14) | 41.70 | Sell |
| William %R | -92.17 | Buy |
| CCI(14) | -47.16 | Neutral |
Buy: 1
Sell: 2
Neutral: 4
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
5.7394
Sell
|
5.2574
Sell
|
| MA20 |
4.6005
Sell
|
4.9485
Sell
|
| MA50 |
4.2496
Sell
|
4.7888
Sell
|
| MA100 |
4.7943
Sell
|
19.44
Sell
|
| MA200 |
16.75
Sell
|
193.61
Sell
|
Buy: 0
Sell: 10
Neutral: 0
Summary: Sell
According to our latest analysis, NDRA could be considered a Strong Sell, with 17 technical analysis indicators signaling 1 Buy signals, 12 signaling Sell signals and 4 Neutral signals. This might not be a good time to consider opening new positions on NDRA, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 40.26 indicates that NDRA is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 57.35 indicates that NDRA is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 63.15 indicates that NDRA is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 41.7 suggests a moderate trend in the market. It indicates that there is more conviction behind the directional movement compared to lower ADX values. You should consider this as a potential opportunity to enter trades in the direction of the trend.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -47.16 indicates that NDRA is not in oversold or overbought territory. It suggests a neutral sentiment in the short term.
Long-term NDRA price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Endra Life Sciences Inc financial reports and earnings history, Endra Life Sciences Inc (NDRA) stock could reach $31.86 by 2030, $16.91 by 2040 and $54.22 by 2050. See the projected annual prices until 2050 of the Endra Life Sciences Inc stock below:
- Endra Life Sciences Inc (NDRA) is expected to reach an average price of $4.8797 in 2035, with a high prediction of $5.6415 and a low estimate of $4.9482. This indicates an $49.69% rise from the last recorded price of $3.26.
- Endra Life Sciences Inc (NDRA) stock is projected to chart a bullish course in 2040, with an average price target of $16.86, representing an $417.15% surge from its current level. The forecast ranges from a conservative $17.10 to a sky-high $16.91.
- Our analysts predict Endra Life Sciences Inc (NDRA) to jump 844.98% by 2045, soaring from $31.11 to an average price of $30.81, potentially reaching $30.99. While $31.11 is the low estimate, the potential upside is significant.
- Endra Life Sciences Inc (NDRA) stock is expected to climb by 2050, reaching an average of $53.76, a $1,549% jump from its current level. However, a wide range of estimates exists, with high and low targets of $54.22 and $54.34, respectively, highlighting the market's uncertainty.
Endra Life Sciences Inc Stock (NDRA) Year by Year Forecast
Endra Life Sciences Inc Stock (NDRA) Price Forecast for 2025
Endra Life Sciences Inc Stock (NDRA) is expected to reach an average price of $11.24 in 2025, with a high prediction of $20.58 and a low estimate of $1.909. This indicates an +244.91% rise from the last recorded price of $3.26.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| June, 2025 | $8.918 | $8.0119 | $7.2226 | +173.56% |
| July, 2025 | $1.0547 | $5.428 | $6.0333 | -67.65% |
| August, 2025 | $3.9041 | $3.0654 | $2.5601 | +19.76% |
| September, 2025 | $1.8275 | $2.1662 | $1.7815 | -43.94% |
| October, 2025 | $6.4642 | $3.9908 | $4.3082 | +98.29% |
| November, 2025 | $5.8156 | $5.7089 | $4.6456 | +78.39% |
| December, 2025 | $6.2224 | $6.5617 | $4.973 | +90.87% |
Endra Life Sciences Inc Stock (NDRA) Price Forecast for 2026
The predicted value for Endra Life Sciences Inc (NDRA) in 2026 is set at an average of $22.91. Estimates vary from a peak of $44.02 to a trough of $1.8145, indicating an +602.91% surge from the present price of $3.26.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $2.5838 | $4.2878 | $4.9797 | -20.74% |
| February, 2026 | $4.2151 | $3.0991 | $2.0991 | +29.30% |
| March, 2026 | $2.1635 | $1.8145 | $5.1635 | -33.64% |
| April, 2026 | $30.84 | $5.0581 | $41.44 | +845.91% |
| May, 2026 | $38.82 | $13.73 | $44.02 | +1,091% |
| June, 2026 | $33.19 | $25.31 | $39.26 | +918.22% |
| July, 2026 | $23.87 | $21.27 | $35.28 | +632.12% |
| August, 2026 | $30.65 | $22.06 | $32.05 | +840.06% |
| September, 2026 | $24.72 | $22.92 | $30.74 | +658.25% |
| October, 2026 | $20.90 | $17.31 | $25.61 | +541.03% |
| November, 2026 | $22.48 | $9.287 | $25.78 | +589.46% |
| December, 2026 | $19.55 | $17.45 | $26.37 | +499.68% |
Endra Life Sciences Inc Stock (NDRA) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Endra Life Sciences Inc (NDRA) is $10.51, with a high forecast of $20.84 and a low forecast of $0.1714. This indicates an +222.33% increase from the last price of $3.26.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $18.33 | $16.63 | $20.84 | +462.21% |
| February, 2027 | $6.1068 | $5.9068 | $18.64 | +87.33% |
| March, 2027 | $1.9781 | $1.0201 | $7.6961 | -39.32% |
| April, 2027 | $0.4187 | $0.1714 | $2.9347 | -87.16% |
| May, 2027 | $1.1427 | $1.0467 | $1.6493 | -64.95% |
| June, 2027 | $4.5894 | $4.2841 | $3.7788 | +40.78% |
| July, 2027 | $4.4108 | $4.7361 | $4.0128 | +35.30% |
| August, 2027 | $6.4522 | $4.8962 | $4.9322 | +97.92% |
| September, 2027 | $6.781 | $6.7376 | $6.9883 | +108.00% |
| October, 2027 | $6.7204 | $6.715 | $6.6643 | +106.15% |
| November, 2027 | $5.3557 | $6.2017 | $6.0764 | +64.29% |
| December, 2027 | $3.0865 | $3.7085 | $5.1571 | -5.32% |
Endra Life Sciences Inc Stock (NDRA) Price Forecast for 2028
In 2028, Endra Life Sciences Inc (NDRA) is projected to reach an average price of $3.976, with a high projection of $4.8247 and a low estimate of $3.1273. This indicates an +21.96% rise from the last price of $3.26.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $3.9519 | $4.2439 | $3.9159 | +21.22% |
| February, 2028 | $3.2513 | $3.1606 | $2.8713 | -0.27% |
| March, 2028 | $4.298 | $3.1273 | $3.756 | +31.84% |
| April, 2028 | $5.1014 | $4.5793 | $4.6194 | +56.48% |
| May, 2028 | $2.6562 | $3.5172 | $4.8247 | -18.52% |
| June, 2028 | $3.0475 | $3.1674 | $2.7758 | -6.52% |
| July, 2028 | $3.3889 | $3.4389 | $3.2982 | +3.95% |
| August, 2028 | $3.2156 | $3.2456 | $3.2042 | -1.36% |
| September, 2028 | $4.537 | $3.231 | $4.037 | +39.17% |
| October, 2028 | $4.2584 | $4.6025 | $4.2778 | +30.63% |
| November, 2028 | $4.0851 | $4.1951 | $4.1891 | +25.31% |
| December, 2028 | $3.8065 | $3.8265 | $3.8005 | +16.76% |
Endra Life Sciences Inc Stock (NDRA) Price Forecast for 2029
The 2029 price forecast for Endra Life Sciences Inc Stock (NDRA) is $12.71 on average, with a high prediction of $25.32 and a low estimate of $0.1032. This represents an +290.00% increase from the previous price of $3.26.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $3.4933 | $3.5333 | $3.5169 | +7.16% |
| February, 2029 | $3.2547 | $3.3047 | $3.3886 | -0.16% |
| March, 2029 | $2.746 | $3.0154 | $2.98 | -15.77% |
| April, 2029 | $2.5574 | $2.6721 | $2.6367 | -21.55% |
| May, 2029 | $2.1702 | $2.1922 | $2.3928 | -33.43% |
| June, 2029 | $1.6256 | $1.7856 | $2.0195 | -50.14% |
| July, 2029 | $0.247 | $0.777 | $1.0209 | -92.42% |
| August, 2029 | $0.8438 | $0.8924 | $0.8283 | -74.12% |
| September, 2029 | $0.3651 | $0.4451 | $0.729 | -88.80% |
| October, 2029 | $0.1118 | $0.1365 | $0.2244 | -96.57% |
| November, 2029 | $0.4162 | $0.3772 | $0.3619 | -87.23% |
| December, 2029 | $27.82 | $0.1032 | $25.32 | +753.53% |
Endra Life Sciences Inc Stock (NDRA) Price Forecast for 2030
Endra Life Sciences Inc Stock (NDRA) is expected to reach an average price of $24.72 in 2030, with a high forecast of $33.39 and a low forecast of $16.05. This signifies an +658.25% surge from the last price of $3.26.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $22.28 | $33.28 | $31.86 | +583.39% |
| February, 2030 | $24.32 | $24.31 | $20.52 | +646.05% |
| March, 2030 | $24.96 | $24.35 | $22.14 | +665.77% |
| April, 2030 | $19.00 | $24.01 | $24.11 | +482.97% |
| May, 2030 | $30.86 | $19.63 | $29.66 | +846.63% |
| June, 2030 | $29.50 | $29.29 | $28.67 | +805.00% |
| July, 2030 | $36.55 | $30.31 | $29.96 | +1,021% |
| August, 2030 | $24.40 | $29.80 | $33.39 | +648.45% |
| September, 2030 | $12.64 | $16.64 | $19.41 | +287.79% |
| October, 2030 | $20.90 | $16.05 | $18.44 | +540.97% |
| November, 2030 | $29.14 | $25.73 | $23.54 | +793.75% |
| December, 2030 | $33.18 | $32.56 | $31.47 | +917.83% |
0.60%
1.22%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):